Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 2
1950 1
1951 4
1953 3
1954 5
1955 6
1956 10
1957 9
1958 8
1959 5
1960 13
1961 21
1962 27
1963 38
1964 101
1965 50
1966 57
1967 59
1968 76
1969 85
1970 71
1971 93
1972 69
1973 102
1974 106
1975 119
1976 100
1977 119
1978 116
1979 118
1980 103
1981 89
1982 132
1983 130
1984 155
1985 163
1986 157
1987 153
1988 125
1989 158
1990 140
1991 148
1992 152
1993 133
1994 135
1995 146
1996 159
1997 150
1998 146
1999 135
2000 176
2001 126
2002 147
2003 160
2004 167
2005 156
2006 201
2007 204
2008 196
2009 194
2010 213
2011 218
2012 244
2013 218
2014 242
2015 223
2016 238
2017 195
2018 167
2019 185
2020 194
2021 140
2022 172
2023 141
2024 66

Text availability

Article attribute

Article type

Publication date

Search Results

8,343 results

Results by year

Filters applied: . Clear all
Page 1
Melphalan flufenamide for relapsed/refractory multiple myeloma.
Nadeem O, Mateos MV, Efebera YA, Paner A, Larocca A, Rodríguez-Otero P, Leleu X, Richardson PG. Nadeem O, et al. Drugs Today (Barc). 2022 Aug;58(8):407-423. doi: 10.1358/dot.2022.58.8.3367680. Drugs Today (Barc). 2022. PMID: 35983927 Review.
Oral melphalan kinetics.
Alberts DS, Chang SY, Chen HS, Evans TL, Moon TE. Alberts DS, et al. Clin Pharmacol Ther. 1979 Dec;26(6):737-45. doi: 10.1002/cpt1979266737. Clin Pharmacol Ther. 1979. PMID: 498715
Melphalan.
[No authors listed] [No authors listed] Rep Carcinog. 2004;11:III164. Rep Carcinog. 2004. PMID: 21089900 No abstract available.
Melphalan.
Betcher DL, Burnham N. Betcher DL, et al. J Pediatr Oncol Nurs. 1990 Jan;7(1):35-6. doi: 10.1177/104345429000700110. J Pediatr Oncol Nurs. 1990. PMID: 2363868 No abstract available.
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma.
Morabito F, Tripepi G, Martino EA, Vigna E, Mendicino F, Morabito L, Todoerti K, Al-Janazreh H, D'Arrigo G, Canale FA, Cutrona G, Neri A, Martino M, Gentile M. Morabito F, et al. Drug Des Devel Ther. 2021 Jul 8;15:2969-2978. doi: 10.2147/DDDT.S295215. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34262262 Free PMC article. Review.
A clickable melphalan for monitoring DNA interstrand crosslink accumulation and detecting ICL repair defects in Fanconi anemia patient cells.
Berrada S, Martínez-Balsalobre E, Larcher L, Azzoni V, Vasquez N, Da Costa M, Abel S, Audoly G, Lee L, Montersino C, Castellano R, Combes S, Gelot C, Ceccaldi R, Guervilly JH, Soulier J, Lachaud C. Berrada S, et al. Nucleic Acids Res. 2023 Aug 25;51(15):7988-8004. doi: 10.1093/nar/gkad559. Nucleic Acids Res. 2023. PMID: 37395445 Free PMC article.
The systemic administration of intravenous melphalan.
Sarosy G, Leyland-Jones B, Soochan P, Cheson BD. Sarosy G, et al. J Clin Oncol. 1988 Nov;6(11):1768-82. doi: 10.1200/JCO.1988.6.11.1768. J Clin Oncol. 1988. PMID: 3054005 Review.
Vasculitis and melphalan.
Skehan MW, Bernath AM. Skehan MW, et al. JAMA. 1978 Dec 15;240(25):2733-4. doi: 10.1001/jama.1978.03290250037017. JAMA. 1978. PMID: 713003 No abstract available.
8,343 results